StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald as Opzelura Attractive in HS
September 16, 2026 7:23 AM
(Updated - September 16, 2026 9:33 AM EDT)
Cantor Fitzgerald analyst Eric Schmidt reiterated a Neutral rating on Incyte ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments